IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,472,000 | 0.0% | 150,000 | 0.0% | 0.02% | +6.2% |
| Q1 2022 | $1,472,000 | +1.0% | 150,000 | 0.0% | 0.02% | -5.9% |
| Q4 2021 | $1,458,000 | +0.3% | 150,000 | 0.0% | 0.02% | -5.6% |
| Q3 2021 | $1,454,000 | +0.2% | 150,000 | 0.0% | 0.02% | +5.9% |
| Q2 2021 | $1,451,000 | – | 150,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TEGEAN CAPITAL MANAGEMENT, LLC | 137,133 | $896,448 | 0.78% |
| Lynwood Capital Management Inc. | 51,400 | $504,000 | 0.56% |
| KRYGER CAPITAL Ltd | 402,232 | $3,945,000 | 0.27% |
| KIM, LLC | 450,000 | $4,415,000 | 0.21% |
| BASSO CAPITAL MANAGEMENT, L.P. | 170,114 | $1,669,000 | 0.18% |
| Knott David M Jr | 36,000 | $353,000 | 0.15% |
| Vestcor Inc | 400,000 | $3,924,000 | 0.15% |
| Castle Creek Arbitrage, LLC | 253,446 | $2,486,000 | 0.14% |
| GLAZER CAPITAL, LLC | 509,934 | $5,002,000 | 0.12% |
| PERISCOPE CAPITAL INC. | 354,600 | $3,479,000 | 0.09% |